M. Dufour

Glucagon-(19-29) exerts a biphasic action on the liver plasma membrane Ca2+ pump which is mediated by G proteins.

D. Bataille, S. Lotersztajn, D. Le-Nguyen, 1990, The Journal of biological chemistry.

Solid‐phase peptide synthesis of human(Nle‐27)‐oxyntomodulin

D. Bataille, A. Kervran, B. Castro, 1986, FEBS letters.

Miniglucagon (glucagon 19-29): a novel regulator of the pancreatic islet physiology.

D. Bataille, S. Dalle, L. Barry, 2002, Diabetes.

A glucagon fragment is responsible for the inhibition of the liver Ca2+ pump by glucagon

D. Bataille, A. Mallat, S. Lotersztajn, 1987, Nature.

Glucagon and Related Peptides. Molecular Structure and Biological Specificity a

P. Blache, D. Bataille, A. Mallat, 1988, Annals of the New York Academy of Sciences.

Endosulfine, an endogenous peptidic ligand for the sulfonylurea receptor: purification and partial characterization from ovine brain.

S. Kuroki, D. Bataille, H. Leray, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Endopeptidase from rat liver membranes, which generates miniglucagon from glucagon.

W. Duckworth, P. Blache, D. Bataille, 1993, The Journal of biological chemistry.

An endogenous ligand for the central sulfonylurea receptor

D. Bataille, A. Cauvin, M. Dufour, 1988, FEBS letters.

Glucagon-(19-29), a Ca2+ pump inhibitory peptide, is processed from glucagon in the rat liver plasma membrane by a thiol endopeptidase.

P. Blache, D. Bataille, S. Lotersztajn, 1990, The Journal of biological chemistry.

Role of G protein beta gamma subunits in the regulation of the plasma membrane Ca2+ pump.

D. Bataille, J. Capeau, A. Mallat, 1992, The Journal of biological chemistry.